NeOnc Technologies Holdings, Inc. (NTHI) shareholders
Close on Nov 18, 2026Market cap $107.90MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Amir F. Heshmatpour Joint filing with AFH Holding & Advisory, LLC (19.64%), Hcwg LLC (5.42%) | 6,488,499 | 34.30% | 13D (active) | Mar 26, 2025 |
| Cinctive Capital Management LP Joint filing with Cinctive GP LLC (9.99%), Richard H. Schimel (9.99%) and 1 more | 2,483,980 | 9.99% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NTHI | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Cinctive Capital Management LP | 1,607,464 | 6.20% | $7.28M | +181,938 | 0.27% |
| Vanguard Capital Management LLC | 504,171 | 1.94% | $2.28M | +288,471 | 0.00% |
| Bank Of America Corp /De/ | 224,412 | 0.87% | $1.02M | −10,984 | 0.00% |
| Westmount Partners, LLC | 197,178 | 0.76% | $893.22K | +153,858 | 0.20% |
| BlackRock, Inc. | 179,850 | 0.69% | $814.72K | +24,012 | 0.00% |
| Geode Capital Management, LLC | 166,120 | 0.64% | $752.79K | +39,267 | 0.00% |
| Vanguard Fiduciary Trust Co | 91,480 | 0.35% | $414.40K | +35,464 | 0.00% |
| State Street Corp | 43,170 | 0.17% | $195.56K | – | 0.00% |
| Northern Trust Corp | 35,871 | 0.14% | $162.50K | +12,600 | 0.00% |
| Global Retirement Partners, LLC | 27,790 | 0.11% | $125.89K | New | 0.00% |
| Marshall Wace, Llp | 21,784 | 0.08% | $98.68K | +9,206 | 0.00% |
| Morgan Stanley | 15,647 | 0.06% | $70.88K | −36,275 | 0.00% |
| Royal Bank of Canada | 15,625 | 0.06% | $71.00K | −1,000 | 0.00% |
| HCR Wealth Advisors | 15,000 | 0.06% | $67.95K | – | 0.01% |
| Vanguard Global Advisers, LLC | 4,265 | 0.02% | $19.32K | – | 0.00% |
| Ancora Advisors, LLC | 2,075 | 0.01% | $9.40K | – | 0.00% |
| Wells Fargo & Company/Mn | 2,000 | 0.01% | $9.06K | +500 | 0.00% |
| UBS Group AG | 1,731 | 0.01% | $7.84K | +1,458 | 0.00% |
| Strategic Wealth Partners, Ltd. | 492 | 0.00% | $2.23K | – | 0.00% |
| Barclays PLC | 453 | 0.00% | $2.05K | −7,609 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 21 | 3M | 12.2% | 2 / 10 | 4 / 8 | 1M | 1M |
| Q1 2026 | 27 | 3M | 11.2% | 10 / 6 | 5 / 5 | 2M | 1M |
| Q4 2025 | 24 | 2M | 8.2% | 8 / 9 | 3 / 3 | 0M | 0M |
| Q3 2025 | 19 | 2M | 6.9% | 11 / 3 | 3 / 2 | 1M | 0M |
| Q2 2025 | 10 | 1M | 2.4% | 7 / 3 | 0 / 1 | 1M | 0M |
| Q1 2025 | 4 | 0M | 0.2% | 4 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
11 funds held NTHI in Q2 2026, 82% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of NTHI | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 310,603 | 1.20% | $1.41M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 188,181 | 0.73% | $852.46K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 53,986 | 0.21% | $250.50K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 35,402 | 0.14% | $160.37K | 0.01% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 20,677 | 0.08% | $95.94K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 15,729 | 0.06% | $72.98K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 12,122 | 0.05% | $56.25K | 0.00% | May 31, 2026 |
| Ultra-Small Company Market Fund | 7,100 | 0.03% | $32.16K | 0.02% | Jun 30, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 4,845 | 0.02% | $21.95K | 0.00% | Jun 30, 2026 |
| 1290 VT Micro Cap Portfolio | 2,351 | 0.01% | $10.65K | 0.00% | Jun 30, 2026 |
| Vanguard Balanced Index Fund | 542 | 0.00% | $2.46K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Amir F. Heshmatpour | CEO, President, Director, 10% owner | 7,873,140 | 30.36% | Nov 13, 2026 |
| Thomas C. Chen | CMO, Director, 10% owner | 4,690,602 | 18.09% | Nov 12, 2026 |
| Keithly Garnett | CFO | 281,410 | 1.09% | Sep 18, 2026 |
| Yousha Neman-Ebrahim | Chief Clinical Officer | 134,760 | 0.52% | Apr 24, 2026 |
| Suh, David Jr. | Chief Accounting Officer | 111,866 | 0.43% | Apr 13, 2026 |
| Patrick Walters | COO | 876,373 | 3.38% | Jun 5, 2025 |
| Ali Mohammad Ahmad Mohammad Alabedin | Director | – | – | Oct 15, 2026 |
| Nasim Shomali | Director | 50,160 | 0.19% | Jul 13, 2026 |
| Ming-Fu (Alan) Chiang | Director | 2,190,049 | 8.44% | Nov 24, 2025 |
| Ishwar Kanwar Puri | Director | – | – | Sep 5, 2025 |
| Jim Delshad | Director | 55,310 | 0.21% | May 19, 2025 |
| Steven L. Giannotta | Director | 50,160 | 0.19% | Mar 28, 2025 |
| Bader Almonawer | Director | 50,160 | 0.19% | Mar 25, 2025 |
| Victoria Medvec | Director | 50,160 | 0.19% | Mar 25, 2025 |
| AFH Holding & Advisory, LLC | 10% owner | – | – | Mar 25, 2025 |
| R. Chen Third Family Limited Partnership T. | 10% owner | 4,586,025 | 17.68% | Mar 25, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Amir F. Heshmatpour CEO, President, Director, 10% owner | Nov 13, 2026 | Buy | +30,000 | $5.02 | $150.50K | 3,353,000 |
| Amir F. Heshmatpour CEO, President, Director, 10% owner | Nov 11, 2026 | Buy | +10,000 | $4.00 | $40.00K | 3,333,000 |
| Amir F. Heshmatpour CEO, President, Director, 10% owner | Nov 11, 2026 | Buy | +10,000 | $4.49 | $44.90K | 3,323,000 |
| Thomas C. Chen CMO, Director, 10% owner | Nov 10, 2026 | Buy | +2,284 | $4.38 | $10.00K | 29,519 |
| Amir F. Heshmatpour CEO, President, Director, 10% owner | Nov 10, 2026 | Buy | +50,000 | $4.19 | $209.60K | 3,313,000 |
| Thomas C. Chen CMO, Director, 10% owner | Nov 9, 2026 | Buy | +2,732 | $3.66 | $10.00K | 27,235 |
| Amir F. Heshmatpour CEO, President, Director, 10% owner | Nov 9, 2026 | Buy | +10,000 | $3.86 | $38.60K | 3,263,000 |
| Amir F. Heshmatpour CEO, President, Director, 10% owner | Nov 6, 2026 | Buy | +40,000 | $3.39 | $135.50K | 3,253,000 |
| Amir F. Heshmatpour CEO, President, Director, 10% owner | Nov 5, 2026 | Buy | +30,000 | $3.17 | $95.01K | 3,213,000 |
| Keithly Garnett CFO | Sep 15, 2026 | Sale(10b5-1 plan) | +5,000 | $3.36 | $16.80K | 237,357 |
| Amir F. Heshmatpour CEO, President, Director, 10% owner | Sep 15, 2026 | Buy | +35,000 | $3.30 | $115.50K | 3,183,000 |
| Amir F. Heshmatpour CEO, President, Director, 10% owner | Sep 14, 2026 | Buy | +15,000 | $3.96 | $59.40K | 3,148,000 |
| Thomas C. Chen CEO, Director, 10% owner | Sep 14, 2026 | Buy | +5,242 | $3.82 | $20.02K | 24,503 |
| Keithly Garnett CFO | Sep 14, 2026 | Buy | +257 | $3.89 | $1,000 | 242,357 |
| Thomas C. Chen CEO, Director, 10% owner | Sep 11, 2026 | Buy | +5,556 | $3.60 | $20.00K | 19,261 |
| Amir F. Heshmatpour CEO, President, Director, 10% owner | Sep 11, 2026 | Buy | +37,000 | $3.67 | $135.79K | 3,133,000 |
| Thomas C. Chen CEO, Director, 10% owner | Aug 18, 2026 | Buy | +12,757 | $5.49 | $70.04K | 13,705 |
| Amir F. Heshmatpour CEO, President, Director, 10% owner | Aug 18, 2026 | Buy | +9,000 | $5.54 | $49.86K | 3,096,000 |
| Thomas C. Chen Chief Scientific Officer, Director, 10% owner | Aug 17, 2026 | Buy | +2,472 | $4.04 | $9.99K | 583,531 |
| Thomas C. Chen CEO, Director, 10% owner | Aug 17, 2026 | Buy | +2,472 | $4.04 | $9.99K | 583,531 |
| Amir F. Heshmatpour CEO, President, Director, 10% owner | Aug 17, 2026 | Buy | +3,000 | $4.37 | $13.11K | 3,087,000 |
| Thomas C. Chen Chief Scientific Officer, Director, 10% owner | Aug 14, 2026 | Buy | +33,787 | $3.85 | $130.08K | 581,059 |
| Thomas C. Chen CEO, Director, 10% owner | Aug 14, 2026 | Buy | +33,787 | $3.85 | $130.08K | 581,059 |
| Amir F. Heshmatpour CEO, President, Director, 10% owner | Aug 14, 2026 | Buy | +12,000 | $3.79 | $45.48K | 3,084,000 |
| Nasim Shomali Director | Jul 10, 2026 | Award | +50,000 | – | – | 50,160 |
| Amir F. Heshmatpour President, Director, 10% owner | May 1, 2026 | Buy | +10,000 | $4.16 | $41.60K | 3,072,000 |
| Amir F. Heshmatpour President, Director, 10% owner | Apr 28, 2026 | Buy | +10,000 | $4.52 | $45.20K | 3,062,000 |
| Thomas C. Chen Chief Scientific Officer, Director, 10% owner | Apr 24, 2026 | Buy | +10,000 | $4.80 | $48.00K | 10,000 |
| Yousha Neman-Ebrahim Chief Clinical Officer | Apr 23, 2026 | Buy | +500 | $4.88 | $2.44K | 134,760 |
| Amir F. Heshmatpour President, Director, 10% owner | Apr 23, 2026 | Buy | +10,000 | $4.90 | $49.00K | 3,052,000 |
| Thomas C. Chen Chief Scientific Officer, Director, 10% owner | Apr 10, 2026 | Buy | +948 | $5.17 | $4.90K | 948 |
| Amir F. Heshmatpour President, Director, 10% owner | Apr 10, 2026 | Buy | +10,000 | $4.90 | $49.00K | 3,042,000 |
| Suh, David Jr. Chief Accounting Officer | Apr 9, 2026 | Buy | +200 | $5.00 | $1.00K | 111,866 |
| Amir F. Heshmatpour President, Director, 10% owner | Apr 9, 2026 | Buy | +5,000 | $5.19 | $25.95K | 3,032,000 |
| Amir F. Heshmatpour President, Director, 10% owner | Apr 8, 2026 | Buy | +10,000 | $5.61 | $56.10K | 3,027,000 |
| Amir F. Heshmatpour President, Director, 10% owner | Apr 6, 2026 | Buy | +5,000 | $6.32 | $31.60K | 3,017,000 |
| Amir F. Heshmatpour President, Director, 10% owner | Apr 2, 2026 | Buy | +20,000 | $6.09 | $121.80K | 3,012,000 |
| Suh, David Jr. Chief Accounting Officer | Mar 1, 2026 | Award | +111,666 | – | – | 111,666 |
| Amir F. Heshmatpour President, Director, 10% owner | Nov 24, 2025 | Buy | +6,000 | $6.51 | $39.06K | 2,992,000 |
| Amir F. Heshmatpour President, Director, 10% owner | Nov 21, 2025 | Buy | +4,000 | $6.50 | $26.00K | 2,986,000 |
| Amir F. Heshmatpour President, Director, 10% owner | Nov 21, 2025 | Buy | +20,000 | $5.98 | $119.60K | 2,982,000 |
| Yousha Neman-Ebrahim Chief Clinical Officer | Nov 20, 2025 | Buy | +1,100 | $6.69 | $7.36K | 134,260 |
| Amir F. Heshmatpour President, Director, 10% owner | Nov 6, 2025 | Award | +1,200,000 | – | – | 2,962,000 |
| Yousha Neman-Ebrahim Chief Clinical Officer | Jun 5, 2025 | Award | +133,000 | – | – | 133,000 |
| Amir F. Heshmatpour President, Director | May 23, 2025 | Buy | +2,000 | $7.39 | $14.78K | 1,762,000 |
| Thomas C. Chen CEO, Director, 10% owner | May 22, 2025 | Buy | +2,709 | $7.38 | $19.99K | 551,668 |
| Keithly Garnett CFO | May 22, 2025 | Buy | +675 | $7.29 | $4.92K | 240,900 |
| Thomas C. Chen CEO, Director, 10% owner | May 21, 2025 | Buy | +2,759 | $7.25 | $20.00K | 548,959 |
| Keithly Garnett CFO | May 19, 2025 | Buy | +135 | $7.23 | $976 | 240,225 |
| Amir F. Heshmatpour President, Director | May 16, 2025 | Buy | +3,510 | $16.87 | $59.21K | 1,760,000 |
| Amir F. Heshmatpour President, Director | May 15, 2025 | Buy | +1,500 | $7.30 | $10.95K | 1,756,490 |
| Amir F. Heshmatpour President, Director | May 14, 2025 | Buy | +1,000 | $7.27 | $7.27K | 1,754,990 |
| Keithly Garnett CFO | May 13, 2025 | Buy | +90 | $7.01 | $631 | 240,090 |
| Amir F. Heshmatpour President, Director | May 13, 2025 | Buy | +990 | $7.01 | $6.94K | 1,753,990 |
| Keithly Garnett CFO | May 13, 2025 | Buy | −90 | $7.01 | $631 | 330,000 |
| Amir F. Heshmatpour President, Director | May 12, 2025 | Buy | +1,400 | $7.23 | $10.12K | 1,753,000 |
| Jim Delshad Director | May 12, 2025 | Buy | +5,000 | $7.22 | $36.10K | 55,310 |
| Thomas C. Chen CEO, Director, 10% owner | May 12, 2025 | Buy | +400 | $7.00 | $2.80K | 546,200 |
| Amir F. Heshmatpour President, Director | May 11, 2025 | Buy | +1,600 | $7.51 | $12.02K | 1,751,600 |
| Jim Delshad Director | Apr 17, 2025 | Buy | +50 | $6.92 | $346 | 50,310 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of NeOnc Technologies's stock actually held short. Settlement fails (shares not delivered on time) peaked at 13,504 shares on Sep 10, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Keithly Garnett Officer | Sep 15, 2026 | 5,000 | $18.90K | Sep 15, 2026 | Restricted Stock Units |
See a number that looks wrong?